← Back to news

Markets

T. Rowe Price Bets Big on Fixed Income With F/m Deal

Y

Why Passive Inflows May be Pulling Down Active Fund Performance

Y

Dimensional, Allspring Latest Firms to Tack on ETF Share Classes

Y

Oil drops more than $2 despite new US sanctions on Iran

Y

Alibaba plunges after announcing $10.2 billion share placement to fund AI push

F

Walmart stock price target reset by JPMorgan after earnings

Y

Ampol Profit Surges as Middle East Disruption Boosts Refining Margins

Y

Alibaba shares fall 8% after $10 billion Hong Kong share sale

Y

Micron: The Competition Has A Better Price

S

Gold, silver rally off ugly crash, but investors remain on edge

Y

Alibaba shares slide after $10.2 billion AI share sale offered at sharp discount

Y

AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated?

Y

Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?

Y

Duos Technologies’ AI Transformation Has Wall Street’s Attention. Here’s How Big This $300 Million Market Cap Company Could Get.

Y

Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business?

Y

Samsung Electronics shares skid as record shareholder returns disappoint

Y

Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?

Y

AstraZeneca’s Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue?

Y

Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?

Y

Nissan scrapped a bank it couldn't afford to build

Y

Micron, Sandisk, and SK Hynix: History Says This About the Memory Trio's Rally

Y

Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?

Y

Fabrinet Just Lost Billions in Market Value Due to Nvidia. Here’s Why the Reaction Is Overdone.

Y

You Can Now Deduct Car Loan Interest but Only if the Final Assembly Happened in America. Here’s How to Check If a Car Qualifies

Y

Alkane Resources uncovers new high-grade gold-antimony domain at Costerfield

Y

The AI Debt Boom Is Helping Push Everyone’s Cost of Capital Higher

Y

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Y

Pfizer’s Turnaround is Gaining Traction, but Can New Products Offset its Patent Cliff?

Y

Retirees can supplement their Social Security with two top dividend stocks

Y

Is Johnson & Johnson’s $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

Y

Diesel Crisis Threatens to Outlast the Middle East War

Y

Bitwise Just Took $1.8 Billion in a Bear Market, Tom Lee Noticed

Y

A Tax Strategy So Aggressive It Built the World’s Largest Hedge Fund and Made Losing Money the Hottest Product on Wall Street

Y

Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?

Y

The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.

Y

Prediction: Oklo Won't Book Its First Commercial Power Revenue Before 2028

Y

Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?

Y

The next big oil trade may have nothing to do with oil stocks

Y

Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?

Y

The $70M business behind Ballerina Farm

Y

Mark Walter Lieutenant Was Key to Dodgers Owner’s Complex Lending Machine

Y

Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet?

Y

Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can

Y

The “Crummey Letter”: The One-Page Note Families Mail Every December to Keep a Million-Dollar Trust Tax-Free.

Y

Goldman Sachs spots huge twist ahead of Nvidia’s earnings

Y

Thermo Fisher vs. Intuitive Surgical: Which Premium Healthcare Stock Deserves its Valuation?

Y

Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?

Y

Micron CEO is doubling down on a cycle-free future

Y

Tesla Maintained Its Majority of the U.S. EV Market in Q2, but That's Not All You Need to Know

Y

Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year

Y